Hematologic Malignancy
Secondary Acute Myeloid Leukemia
CI-CAN-00001489Explore in graph →
Hematologic46 active trials2 approved drugs
- NCIt
- C25765
Loading cancer entity…
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00001489Explore in graph →
Provenance
Every source that supplied a code, alias, edge, observation or derived value, with the ingest runs involved.
| Source | License | Contributions | Ingest runs | Last retrieved |
|---|---|---|---|---|
| EMA — European public assessment reports (centrally authorised medicines) ema | approved | Approvals | — | Sep 16, 2026, 05:01 AM UTC |
| NCI Thesaurus (NCIt) ncit-evs | approved | Aliases, Codes, Description, Hierarchy, Source Records | ING-NCITEVS-20260908-000001 | Sep 8, 2026, 09:44 AM UTC |
| PubMed (NCBI E-utilities) pubmed | approved | Literature Counts | ING-PUBMED-20260928-000001 | Sep 28, 2026, 03:00 AM UTC |
Identifiers
Every upstream identifier is kept with its match type; nothing is buried in JSON.
Names
| Alias | Type | Terminology | Language |
|---|---|---|---|
| Secondary Acute Myeloid Leukemia | preferred | NCIt | en |
| Secondary Acute Granulocytic Leukemia | synonym | NCIt | en |
| Secondary Acute Myeloblastic Leukemia | synonym | NCIt | en |
| Secondary Acute Myelogenous Leukemia | synonym | NCIt | en |
| Secondary Acute Myeloid Leukemia (AML) | synonym | NCIt | en |
| Secondary AGL | synonym | NCIt | en |
| SECONDARY_AML | synonym | NCIt | en |
Change history
Creation, updates, merges and ranking changes recorded for this entity.